Effectiveness of Atorvastatin on reducing of death and illness after catheterizatio

Phase 3

Recruiting

Conditions: Complications after permanent catheterization (permcath).
Other specified complications of cardiac and vascular prosthetic devices, implants and grafts
T82.8

Registration Number: IRCT20201028049175N10

Lead Sponsor: Arak University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 228

Inclusion Criteria

Patients older than 18 years old
Patients who have informed consent
Patients who need permanent dialysis
Sinus rhythm heart

Exclusion Criteria

Patients with chronic atrial fibrillation (AF)
Patients with liver failure
Patients with using class I and III of anti-arrhythmic drugs
Patients with using corticosteroid drugs
Patients with history of statin use in control group

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of cardiac arrhythmia. Timepoint: During 24 hours after catheterization. Method of measurement: Heart monitoring.;Frequency of myocardial infarction. Timepoint: During 24 hours after catheterization. Method of measurement: Heart monitoring.;Catheter site infection. Timepoint: Every 2 weeks till 6 month. Method of measurement: Physical examination.;Catheter function. Timepoint: Every 2 weeks till 6 month. Method of measurement: Physical examination.;Catheter stenosis. Timepoint: Every 2 weeks till 6 month. Method of measurement: Physical examination.;Mortality. Timepoint: During 24 hours after catheterization. Method of measurement: Number.

Secondary Outcome Measures